[1]
|
M. Zasloff, “Antimicrobial Peptides of Multicellular Organisms,” Nature, Vol. 415, No. 6870, 2001, pp. 389395.doi:10.1038/415389a
|
[2]
|
N. H. Salzman, D. Ghosh, K. M. Huttner, Y. Paterson and C. L. Bevins, “Protection against Enteric Salmonellosis in Transgenic Mice Expressing a Human Intestinal Defensing,” Nature, Vol. 422, No. 6931, 2003, pp. 522-526.
doi:10.1038/nature01520
|
[3]
|
T. Ayabe, D. P. Satchell, C. L. Wilson, W. C. Parks, M. E. Selsted and A. J. Ouellette, “Secretion of Microbicidal Alpha-Defensins by Intestinal Paneth Cells in Response to Bacteria,” Nature Immunology, Vol. 1, No. 2, 2000, pp. 113-118. doi:10.1038/77783
|
[4]
|
A. J. Ouellette, “Paneth Cell Alpha-Defensins: Peptide Mediators of Innate Immunity in the Small Intestine,” Springer Seminars in Immunopathology, Vol. 27, No. 2, 2005, pp. 133-146.
doi:10.1007/s00281-005-0202-x
|
[5]
|
J. Wehkamp, N. H. Salzman, E. Porter, S. Nuding, M. Weichenthal, R. E. Petras, B. Shen, E. Schaeffeler, M. Schwab, R. Linzmeier, R. W. Feathers, H. Chu, H. Lima Jr., K. Fellermann, T. Ganz, E. F. Stange and C. L. Bevins, “Reduced Paneth Cell Alpha-Defensins in Ileal Crohn’s Disease,” The Proceedings of the National Academy of Sciences USA, Vol. 102, No. 50, 2005, pp. 1812918134. doi:10.1073/pnas.0505256102
|
[6]
|
M. N. Becker, G. Diamond, M. W. Verghese and S. H. Randell, “CD14-Dependent Lipopolysaccharide-Induced Beta-Defensin-2 Expression in Human Tracheobronchial Epithelium,” The Journal of Biological Chemistry, Vol. 275, No. 38, 2000, pp. 29731-29736.
doi:10.1074/jbc.M000184200
|
[7]
|
C. Fulton, G. M. Anderson, M. Zasloff, R. Bull and A. G. Quinn, “Expression of Natural Peptide Antibiotics in Human Skin,” Lancet, Vol. 350, 1997, pp. 1750-1751.
doi:10.1016/S0140-6736(05)63574-X
|
[8]
|
H. P. Jia, B. C. Schutte, A. Schudy, R. Linzmeier, J. M. Guthmiller, G. K. Johnson, B. F. Tack, J. P. Mitros, A. Rosenthal, T. Ganz and P. B. McCray Jr., “Discovery of New Human Beta-Defensins Using a Genomics-Based Approach,” Gene, Vol. 263, No. 1-2, 2001, pp. 211-218.
doi:10.1016/S0378-1119(00)00569-2
|
[9]
|
P. K. Singh, H. P. Jia, K. Wiles, J. Hesselberth, L. Liu, B. A. Conway, E. P. Greenberg, E. V. Valore, M. J. Welsh, T. Ganz, B. F. Tack and P. B. McCray Jr., “Production of Beta-Defensins by Human airway Epithelia,” The Proceedings of the National Academy of Sciences USA, Vol. 95, No. 25, 1998, pp. 14961-14966.
doi:10.1073/pnas.95.25.14961
|
[10]
|
O. E. Sorensen, D. R. Thapa, A. Rosenthal, L. Liu, A. A. Roberts and T. Ganz, “Differential Regulation of BetaDefensin Expression in Human Skin by Microbial Stimuli,” The Journal of Immunology, Vol. 74, No. 8, 2005, pp. 4870-4879.
|
[11]
|
A. Y. Liu, D. Destoumieux, A. V. Wong, C. H. Park, E. V. Valore, L. Liu and T. Ganz, “Human-Defensin-2 Production in Keratinocytes Is Regulated by Interleukin-1, Bacteria, and the State of Differentiation,” Journal of Investigative Dermatology , Vol. 118, 2002, pp. 275-281.
doi:10.1046/j.0022-202x.2001.01651.x
|
[12]
|
Y. Tsutsumi-Ishii and I. Nagaoka, “Modulation of Human β-Defensin-2 Transcription in Pulmonary Epithelial Cells by Lipopolysaccharide-Stimulated Mononuclear Phagocytes via Proinflammatory Cytokine Production,” The Journal of Immunology, Vol. 170, 2003, p. 4226.
|
[13]
|
J. Harder, J. Bartels, E. Christophers and J. M. Schroder, “Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic,” The Journal of Biological Chemistry, Vol. 276, No. 51, 2001, pp. 5707-5713. doi:10.1074/jbc.M008557200
|
[14]
|
J. Wehkamp, J. Harder, M. Weichenthal, O. Mueller, K. R. Herrlinger, K. Fellermann, J. M. Schroeder and E. F. Stange, “Inducible and Constitutive β-Defensins Are Differentially Expressed in Crohn’s Disease and Ulcerative Colitis,” Inflammatory Bowel Diseases, Vol. 9, No. 4, 2003, pp. 215-223.
doi:10.1097/00054725-200307000-00001
|
[15]
|
J. P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J. P. Cézard, J. Belaiche, S. Almer, C. Tysk, C. A. O’Morain, M. Gassull, V. Binder, Y. Finkel, A. Cortot, R. Modigliani, P. Laurent-Puig, C. Gower-Rousseau, J. Macry, J. F. Colombel, M. Sahbatou and G. Thomas, “Association of NOD2 Leucine-Rich Repeat Variants with Susceptibility to Crohn’s Disease,” Nature, Vol. 411, No. 6837, 2001, pp. 599-603. doi:10.1038/35079107
|
[16]
|
P. Fehlbaum, M. Rao, M. Zasloff and G. M. Anderson, “An Essential Amino Acid Induces Epithelial Beta-Defensin Expression,” The Proceedings of the National Academy of Sciences USA, Vol. 97, No. 23, 2000, pp. 1272312728. doi:10.1073/pnas.220424597
|
[17]
|
S. K. Moon, H. Y. Lee, J. D. Li, M. Nagura, S. H. Kang, Y. M. Chun, F. H. Linthicum, T. Ganz, A. Andalibi and D. J. Lim, “Activation of a Src-Dependent Raf-MEK1/2ERK Signaling Pathway Is Required for IL-1a-Induced Upregulation of h-Defensin 2 in Human Middle Ear Epithelial Cells,” Biochimica et Biophysica Acta, Vol. 1590, No. 1-3, 2002, pp. 41-51.
doi:10.1016/S0167-4889(02)00196-9
|
[18]
|
C. Bezencxon, J. le Coutre and S. Damak, “Taste-Signaling Proteins Are Coexpressed in Solitary Intestinal Epithelial Cells,” Chemical Senses, Vol. 32, No. 1, 2007, pp. 41-49. doi:10.1093/chemse/bjl034
|
[19]
|
S. Okumura, H. Baba, T. Kumada, K. Nanmoku, H. Nakajima, Y. Nakane, K. Hioki and K. Ikenaka, “Cloning of a G-Protein-Coupled Receptor That Shows an Activity to Transform NIH3T3 Cells and Is Expressed in Gastric Cancer Cells,” Cancer Science, Vol. 95, No. 2, 2004, pp. 131-135. doi:10.1111/j.1349-7006.2004.tb03193.x
|
[20]
|
B. F. O’Dowd, T. Nguyen, A. Marchese, R. Cheng, K. R. Lynch, H. H. Heng, L. F. Kolakowski Jr. and S. R. George, “Discovery of Three Novel G-Protein-Coupled Receptor Genes,” Genomics, Vol. 47, No. 15, 1998, pp. 310-313. doi:10.1006/geno.1998.5095
|
[21]
|
M. Wan, A. Sabirsh, A. Wetterholm, B. Agerberth and J. Z. Haeggstrom, “Leukotriene B4 Triggers Release of the Cathelicidin LL-37 from Human Neutrophils: Novel LipidPeptide Interactions in Innate Immune Responses,” The FASEB Journal, Vol. 21, No. 11, 2007, pp. 2897-2905.
doi:10.1096/fj.06-7974com
|
[22]
|
H. Dommisch, W. O. Chung, M. G. Rohani, D. Williams, M. Rangarajan, M. A. Curtis and B. A. Dale, “ProteaseActivated Receptor 2 Mediates Human Beta-Defensin 2 and CC Chemokine Ligand 20 mRNA Expression in Response to Proteases Secreted by Porphyromonas gingivalis,” Infection and Immunity, Vol. 75, No. 9. 2007, pp. 43264333. doi:10.1128/IAI.00455-07
|
[23]
|
L. R. Howe and C. J. Marshall, “Lysophosphatidic Acid Stimulates Mitogen-Activated Protein Kinase Activation via a G-Protein-Coupled Pathway Requiring p21ras and p74raf-1,” The Journal of Biological Chemistry, Vol. 268, No. 28, 1993, pp. 20717-20720.
|
[24]
|
P. L. Hordijk, I. Verlaan, E. J. van Corven and W. H. Moolenaar, “Protein Tyrosine Phosphorylation Induced by Lysophosphatidic Acid in Rat-1 Fibroblasts. Evidence that Phosphorylation of Map Kinase Is Mediated by the Gi-p21ras Pathway,” The Journal of Biological Chemistry, Vol. 269, No. 1, 1994, pp. 645-651.
|
[25]
|
V. J. LaMorte, E. D. Kennedy, L. R. Collins, D. Goldstein, A. T. Harootunian, J. H. Brown and J. R. Feramisco, “A Requirement for Ras Protein Function in ThrombinStimulated Mitogenesis in Astrocytoma Cells,” The Journal of Biological Chemistry, Vol. 268, No. 26, 1993, pp. 19411-19415.
|
[26]
|
J. E. Duff, B. C. Berk and M. A. Corson, “Angiotensin II Stimulates the pp44 and pp42 Mitogen-Activated Protein Kinases in Cultured Rat Aortic Smooth Muscle Cells,” Biochemical and Biophysical Research Communications, Vol. 188, No. 1, 1992, pp. 257-264.
doi:10.1016/0006-291X(92)92378-B
|
[27]
|
Y. Ishida, Y. Kawahara, T. Tsuda, M. Koide and M. Yokoyama, “Involvement of MAP Kinase Activators in Angiotensin II-Induced Activation of MAP Kinases in Cultured Vascular Smooth Muscle Cells,” FEBS Letters, Vol. 310, No. 1, 1992, pp. 41-45.
doi:10.1016/0014-5793(92)81142-9
|
[28]
|
B. E. Hawes, T. van Biesen, W. J. Koch, L. M. Luttrell and R. J. Lefkowitz, “Distinct Pathways of Giand GqMediated Mitogen-Activated Protein Kinase Activation,” The Journal of Biological Chemistry, Vol. 270, 1995, pp. 17148-17153. doi:10.1074/jbc.270.29.17148
|
[29]
|
T. van Biesen, B. E. Hawes, D. K. Luttrell, K. M. Krueger, K. Touhara, E. Porfiri, M. Sakaue, L. M. Luttrell, and R. J. Lefkowitz, “Receptor-Tyrosine-Kinaseand G Beta Gamma-Mediated MAP Kinase Activation by a Common Signalling Pathway,” Nature, Vol. 376, No. 6543, 1995, pp. 781-784. doi:10.1038/376781a0
|
[30]
|
V. Mieulet, L. Yan, C. Choisy, K. Sully, J. Procter, A. Kouroumalis, S. Krywawych, M. Pende, S. C. Ley, C. Moinard and R. F. Lamb, “TPL-2-Mediated Activation of MAPK Downstream of TLR4 Signaling Is Coupled to Arginine Availability,” Science Signaling, Vol. 3, No. 135, 2010, p. ra61. doi:10.1126/scisignal.2000934
|
[31]
|
S. K. Moon, H. Y. Lee, J. D. Li, M. Nagura, S. H. Kang, Y. M. Chun, F. H. Linthicum, T. Ganz, A. Andalibi and D. J. Lim, “Activation of a Src-Dependent Raf-MEK1/2ERK Signaling Pathway Is Required for IL-1a-Induced Upregulation of h-Defensin 2 in Human Middle Ear Epithelial Cells,” Biochimica et Biophysica Acta, Vol. 1590, No. 1-3, 2002, pp. 41-51.
doi:10.1016/S0167-4889(02)00196-9
|
[32]
|
N. Wettschureck and S. Offermanns, “Mammalian G Proteins and Their Cell Type Specific Functions,” Physiological Reviews, Vol. 85, No. 4, 2005, pp. 1159-1204.
doi:10.1152/physrev.00003.2005
|
[33]
|
Y. Chen-Izu, R. P. Xiao, L.T. Izu, H. Cheng, M. Kuschel, H. Spurgeon and E. G. Lakatta, “G(i)-Dependent Localization of Beta(2)-Adrenergic Receptor Signaling to LType Ca(2+) Channels,” Biophysical Journal, Vol. 79, No. 5, 2000, pp. 2547-2556.
doi:10.1016/S0006-3495(00)76495-2
|
[34]
|
H. J. Lee, H. C. Mun, N. C. Lewis, M. F. Crouch, E. L. Culverston, R. S. Mason and A. D. Conigrave, “Allosteric Activation of the Extracellular Ca2+-Sensing Receptor by L-Amino Acids Enhances ERK1/2 Phosphorylation,” Biochemical Journal, Vol. 404, Part 1, 2007, pp. 141-149.
doi:10.1042/BJ20061826
|
[35]
|
T. Witth?ft, C. S. Pilz, K. Fellermann, M. Nitschke, E. F. Stange and D. Ludwig, “Enhanced Human β-Defensin-2 (hBD-2) Expression by Corticosteroids Is Independent of NF-κB in Colonic Epithelial Cells (CaCo2),” Digestive Diseases and Sciences, Vol. 50, No. 7, 2005, pp. 12521259.
|
[36]
|
M. H. Giaffer, G. North and C. D. Holdsworth, “Controlled Trial of Polymeric versus Elemental Diet in Treatment of Active Crohn’s Disease,” Lancet, Vol. 335, No. 8693, 1990, pp. 816-819.
doi:10.1016/0140-6736(90)90936-Y
|
[37]
|
H. Sherman, N. Chapnik and O. Froy, “Albumin and Amino Acids Upregulate the Expression of Human BetaDefensin 1,” Molecular Immunology, Vol. 43, No. 10, 2006, pp. 1617-1623. doi:10.1016/j.molimm.2005.09.013
|